Job Advert: CEPI-UVRI Centralised Laboratory Network (CLN)

Location: Uganda Virus Research Institute

Position: Statistician

About Us: CEPI's Centralised Laboratory Network (CLN) was launched in 2020 to provide
standardised testing support to vaccine developers worldwide. The CLN is the world's largest
consortium of laboratories that offers critical testing services to vaccine developers, ensuring
consistency in data readouts, which streamlines the assessment of multiple vaccine candidates.
The harmonised data generated by the CLN accelerates vaccine development against CEPI's
priority pathogens and potential epidemics, including Disease X. The CEPI CLN has expanded to
include UVRI in Uganda in partnership with MRC/UVRI and LSHTM (MUL), aiming to reduce
sample transfer and testing times for vaccine developers in the region while bolstering outbreak
preparedness infrastructure worldwide.

Now, the CEPI CLN has expanded its geographical footprint to include UVRI in Uganda in
partnership with (MUL). This expansion aims to reduce sample transfer and testing times for
vaccine developers in the region while bolstering sustainable outbreak preparedness
infrastructure worldwide. Our mission is clear: to propel the development of vaccines against
priority pathogens such as Ebola, Marburg, and emerging threats, driving innovation, and
safeguarding public health on a global scale.

Position Summary:
This Statistician position within the CEPI-UVRI CLN offers a unique opportunity for Ugandans to
apply advanced statistical methodologies to ongoing Immunology studies. By collaborating
closely with project leads and Principal Investigators, you will shape the design, analysis, and
interpretation of data, playing a crucial role in optimising assays for detecting responses to Ebola,
Marburg, and other emerging threats, thus enhancing preparedness for epidemics and future
vaccine trials.

Key Responsibilities:
• Collaborate with multidisciplinary teams to design and implement statistical methodologies for
assay optimisation and immune assessments.
• Contribute to the development and preparation of protocols for new research studies.
• Analyze and interpret data to identify trends, patterns, and potential areas for improvement.
• Develop and validate statistical models to enhance the sensitivity and specificity of our
assays.
• Conduct literature reviews to stay updated with relevant advancements.
• Contribute to the dissemination of research findings through publications and presentations.
• Address operational challenges in data procurement within protocol design.
• Contribute to the CLN's mission of accelerating vaccine development timelines and enhancing
global outbreak preparedness.
• Attend and input study protocol meetings and fulfil additional duties as required.

Page 1 of 2
Qualifications:

Essential:
• Advance degree (at least Masters) Statistics, Biostatistics, Medical statistics, Biostatistics,
Bioinformatics, or a related field.
• Proficiency in statistical software such as R, SAS, or Python
• Strong understanding of experimental design and data analysis techniques.
• Excellent communication skills with the ability to convey complex concepts to diverse
audiences.

A background in Mathematics will be an added advantage.

Benefits:
• Opportunity to work on cutting edge research with global impact
• Competitive salary and benefits package.
• Professional development opportunities and career growth
• Collaborative and dynamic work environment

Application Process:

To apply for this position, please submit your CV, copies of all your academic credentials and
national ID along with a cover letter detailing your relevant experience and why you believe you
are suited for this role, and recommendation from two professional referees. Applications should
be sent to vmirembe@uvri.go.ug

Deadline for Applications:

30th April 2024

Together, let's build a safer, healthier world for all.

CEPI-UVRI CLN is an equal opportunity employer committed to diversity and inclusion. We

encourage applications from individuals of all backgrounds and experiences.
.

Page 2 of 2